Can businesses ask about your COVID-19 vaccination status?
By Amber Ainsworth
Health director says state still aiming for vaccine benchmarks despite CDC mask announcement
Elizabeth Hertel from MDHHS said that the recent announcement by the CDC allowing those vaccinated to go without masks indoors in most situations is leading to cautious optimism. The state is following the CDC recommendation but hopes it provides an incentive for those waiting to get vaccinated.
DETROIT (FOX 2) - Michigan s current mask mandate allows vaccinated people to be inside without a mask. However, there have been questions about how it can be proved that a person has or has not received the COVID-19 vaccine.
Yes, Businesses Can Ask About Your COVID-19 Vaccination Status
Well, it seems people on social media have found something new to argue about.
There s been a ton of debate on whether or not a business has the right to ask to see your vaccination card. People have been going round and round about this ever since Michigan updated the mask mandate which allows vaccinated people to be inside without a mask. Once that announcement was made, some businesses said they would ask customers to show their proof of vaccination.
Get our free mobile app
People keep saying that businesses can t ask for proof of vaccination because HIPAA prevents them from sharing their medical information, including their vaccination status. According to an article from Fox 2 Detroit, this is not protected by HIPAA
Can businesses ask about your COVID-19 vaccination status? fox26houston.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fox26houston.com Daily Mail and Mail on Sunday newspapers.
Abstract
While it is now widely accepted that host inflammatory responses contribute to lung injury, the pathways that drive severity and distinguish coronavirus disease 2019 (COVID-19) from other viral lung diseases remain poorly characterized. We analyzed plasma samples from 471 hospitalized patients recruited through the prospective multicenter ISARIC4C study and 39 outpatients with mild disease, enabling extensive characterization of responses across a full spectrum of COVID-19 severity. Progressive elevation of levels of numerous inflammatory cytokines and chemokines (including IL-6, CXCL10, and GM-CSF) were associated with severity and accompanied by elevated markers of endothelial injury and thrombosis. Principal component and network analyses demonstrated central roles for IL-6 and GM-CSF in COVID-19 pathogenesis. Comparing these profiles to archived samples from patients with fatal influenza, IL-6 was equally elevated in both conditions whereas GM-CSF was prominent only in